Shandong Suncadia Medicine Co., Ltd.

This early-stage study tests a new drug called HRS-3802 in 100 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants will receive the drug …

This study tests an experimental tablet called HRS-7085 in adults with moderate to severe ulcerative colitis, a chronic bowel disease. About 66 participants will receive either the drug or a placebo to see if it safely reduces symptoms like diarrhea and rectal bleeding. The goal …

This early-phase study tests a new drug called HRS-7058 in people with advanced solid tumors that have a specific KRAS G12C mutation. The main goals are to find a safe dose and check how well the drug works. About 233 adults aged 18 to 75 with advanced cancer will take part.

This study tests an experimental drug called HRS-7535 in 225 adults who have both heart failure (with a mildly reduced or preserved pumping ability) and obesity. The main goal is to see if the drug helps with weight loss and reduces inflammation over 36 weeks. Participants are ra…

This study tests a new drug called HRS-1893 in 48 people with a type of heart failure where the heart pumps well but is too stiff (heart failure with preserved ejection fraction). The main goal is to check if the drug is safe and tolerable. Researchers will also measure changes i…

This study tests a new drug called HRS-7058 combined with other cancer drugs in people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find safe doses and see if the combination shrinks tumors. About 300 adults aged 18 to 75 with good p…

This study tests a new drug called HRS-8080 in 240 women with advanced breast cancer that has worsened after hormone therapy. Participants will either receive HRS-8080 or another treatment chosen by their doctor. The main goal is to see if HRS-8080 can delay cancer growth longer …

This study tests an experimental drug called HRS-1780 in 60 adults with primary aldosteronism, a condition where the adrenal glands make too much of a hormone that raises blood pressure. The drug is compared to a placebo to see if it safely lowers blood pressure better than no tr…

This study tests a new medicine called HRS-1301 to see how well it lowers cholesterol in people with high cholesterol. About 189 adults will take either the drug or a placebo for 12 weeks. The main goal is to measure the drop in 'bad' cholesterol (LDL-C) and check for side effect…

This study tests a new drug called HRS-7058 combined with other anti-tumor medicines in people with solid tumors. The goal is to find a safe dose and see if the combination shrinks tumors. About 100 adults aged 18 to 75 with good performance status are being recruited.

This study tests an experimental drug called HRS-1780 in about 2,000 adults with chronic kidney disease. The goal is to see if adding HRS-1780 to standard care can slow the loss of kidney function better than a placebo. Participants take the drug or placebo for 32 months while do…

This early-stage study tests a new drug called HRS-6208 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors or slow their growth. About 206 adults a…

This study tests a new drug called HRS-8080 against standard hormone therapy in women with high-risk early breast cancer. Participants must have already received at least 2 years of standard hormone therapy after surgery. The goal is to see if HRS-8080 better prevents cancer from…

This study tests several new drug combinations in people with advanced breast cancer that cannot be removed by surgery or has spread. The goal is to find safe doses and see if the drugs shrink tumors. About 300 adults will take part. The study is currently recruiting.

This study tests several new drug combinations in people with advanced breast cancer that cannot be removed by surgery or has spread. The goal is to find safe doses and see if the drugs can shrink tumors. About 180 adults will take part.

This study looks at the long-term safety of a drug called HRS-1893 in 300 people with hypertrophic cardiomyopathy, a condition where the heart muscle thickens. Participants must have taken HRS-1893 in a previous study. Researchers will track side effects and heart function over t…

This study tests a new combination of two drugs (HRS-8080 and dalpiciclib) for people with a common type of advanced breast cancer (ER-positive, HER2-negative) that cannot be removed by surgery or has spread. About 146 women aged 18-75 will take part to find the best dose and see…

This study tests a new drug, HRS-8080, combined with dalpiciclib against a standard treatment (fulvestrant plus dalpiciclib) in 912 women with advanced breast cancer that no longer responds to hormone therapy. The goal is to see which combination better delays cancer growth. Part…

This study tests a new medicine called HRS-2129 for people with diabetic nerve pain in their hands and feet. About 168 Chinese adults will receive either the new drug, a placebo (dummy pill), or an approved painkiller (pregabalin) to see if it safely reduces pain. The main goal i…

This study tests a new medicine called HRS-2129 for pain after orthopedic surgery (like knee or hip replacement). About 195 adults having planned surgery will receive the drug to see if it safely reduces pain and what dose works best. The goal is to help people feel more comforta…

This early-stage study tests an experimental drug called HRS-2129 in 200 people with moderate to severe knee osteoarthritis pain. The goal is to see if different doses can reduce pain and improve knee function compared to a placebo or an active control. Participants must stop oth…

This study is testing a new medicine called HRS-2129 to see if it can safely reduce pain after abdominal surgery. About 360 adults having abdominal surgery will receive either HRS-2129 or a comparator drug. The main goal is to measure how much pain relief patients get during the …

This study checks if two different tablet forms of the drug HRS-1893 are processed the same way in the body. It involves 36 healthy adults aged 18 to 55. The main goal is to measure drug levels in the blood, not to treat any condition.